{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:00:07Z","timestamp":1790157607203,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ubiquitination plays a critical role in hepatocellular carcinoma (HCC) pathogenesis and is closely linked to ferroptosis. This study investigates the function of OTUB1, a deubiquitinase overexpressed in HCC, in regulating autophagy-dependent ferroptosis. Using integrated bioinformatics, biochemical assays, and xenograft models, we demonstrated that OTUB1 is upregulated in HCC and correlates with poor prognosis. Functionally, OTUB1 knockdown suppressed proliferation and induced ferroptosis, whereas its overexpression promoted malignancy. Mechanistically, OTUB1 competitively binds to p62\/SQSTM1, thereby suppressing autophagic flux. Crucially, we identified that OTUB1 stabilizes p62 via non-canonical, D88-dependent deubiquitination by specifically removing K48-linked polyubiquitin chains. This stabilization hinders the initiation of autophagy-dependent ferroptosis. Pharmacological inhibition of autophagy abrogated the ferroptosis induced by OTUB1 knockdown. Furthermore, inhibiting OTUB1 sensitized HCC tumors to Lenvatinib, resulting in synergistic anti-tumor efficacy in vivo. Collectively, these findings reveal that OTUB1 drives HCC progression by stabilizing p62 to block autophagy-dependent ferroptosis. Targeting the OTUB1-p62 axis represents a novel therapeutic strategy to overcome drug resistance and improve outcomes in advanced HCC.<\/jats:p>","DOI":"10.1038\/s41420-026-03241-5","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:55:11Z","timestamp":1784724911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["OTUB1 inhibits autophagy-dependent ferroptosis in hepatocellular carcinoma by stabilizing p62 via non-canonical deubiquitination"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0753-6307","authenticated-orcid":false,"given":"Pengcheng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7016-9018","authenticated-orcid":false,"given":"Nima","family":"Saeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4944-2937","authenticated-orcid":false,"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"3241_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3241_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","journal-title":"Nat Rev Dis Primers"},{"key":"3241_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","volume":"20","author":"C Yang","year":"2023","unstructured":"Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W, et al. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2023;20:203\u201322.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3241_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","volume":"158","author":"ZJ Brown","year":"2023","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM, et al. Management of hepatocellular carcinoma: a review. JAMA Surg. 2023;158:410\u201320.","journal-title":"JAMA Surg"},{"key":"3241_CR5","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.3390\/cancers14225525","volume":"14","author":"S Wang","year":"2022","unstructured":"Wang S, Wang Y, Yu J, Wu H, Zhou Y. Lenvatinib as first-line treatment for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Cancers. 2022;14:5525","journal-title":"Cancers"},{"key":"3241_CR6","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/liv.15953","volume":"44","author":"Y Qin","year":"2024","unstructured":"Qin Y, Han S, Yu Y, Qi D, Ran M, Yang M, et al. Lenvatinib in hepatocellular carcinoma: resistance mechanisms and strategies for improved efficacy. Liver Int. 2024;44:1808\u201331.","journal-title":"Liver Int"},{"key":"3241_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3241_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"3241_CR9","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.62347\/SIGP9279","volume":"14","author":"D Li","year":"2024","unstructured":"Li D, Zhang M, Liu J, Li Z, Ni B. Potential therapies for HCC involving targeting the ferroptosis pathway. Am J Cancer Res. 2024;14:1446\u201365.","journal-title":"Am J Cancer Res"},{"key":"3241_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen Q, Zheng W, Guan J, Liu H, Dan Y, Zhu L, et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ. 2023;30:137\u201351.","journal-title":"Cell Death Differ"},{"key":"3241_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03718-4","volume":"12","author":"Q Wang","year":"2021","unstructured":"Wang Q, Bin C, Xue Q, Gao Q, Huang A, Wang K, et al. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2\/GPX4 axis. Cell Death Dis. 2021;12:426.","journal-title":"Cell Death Dis"},{"key":"3241_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcancer.2019.03.002","volume":"66","author":"B Zhou","year":"2020","unstructured":"Zhou B, Liu J, Kang R, Klionsky DJ, Kroemer G, Tang D. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. 2020;66:89\u2013100.","journal-title":"Semin Cancer Biol"},{"key":"3241_CR13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s42003-024-06999-5","volume":"7","author":"J Cao","year":"2024","unstructured":"Cao J, Wu S, Zhao S, Wang L, Wu Y, Song L, et al. USP24 promotes autophagy-dependent ferroptosis in hepatocellular carcinoma by reducing the K48-linked ubiquitination of Beclin1. Commun Biol. 2024;7:1279.","journal-title":"Commun Biol"},{"key":"3241_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s13402-023-00913-7","volume":"47","author":"L Peng","year":"2024","unstructured":"Peng L, Wu T, Liu Y, Zhao D, He W, Yuan Y. OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination. Cell Oncol. 2024;47:987\u20131004.","journal-title":"Cell Oncol"},{"key":"3241_CR15","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1182\/blood.2020005199","volume":"137","author":"Y Xu","year":"2021","unstructured":"Xu Y, Xu M, Tong J, Tang X, Chen J, Chen X, et al. Targeting the Otub1\/c-Maf axis for the treatment of multiple myeloma. Blood. 2021;137:1478\u201390.","journal-title":"Blood"},{"key":"3241_CR16","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/s41418-022-00971-8","volume":"29","author":"X Han","year":"2022","unstructured":"Han X, Ren C, Lu C, Qiao P, Yang T, Yu Z. Deubiquitination of MYC by OTUB1 contributes to HK2-mediated glycolysis and breast tumorigenesis. Cell Death Differ. 2022;29:1864\u201373.","journal-title":"Cell Death Differ"},{"key":"3241_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13578-020-00408-0","volume":"10","author":"K Zhou","year":"2020","unstructured":"Zhou K, Mai H, Zheng S, Cai W, Yang X, Chen Z, et al. OTUB1-mediated deubiquitination of FOXM1 up-regulates ECT-2 to promote tumor progression in renal cell carcinoma. Cell Biosci. 2020;10:50.","journal-title":"Cell Biosci"},{"key":"3241_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","volume":"42","author":"D Li","year":"2023","unstructured":"Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 2023;42:83\u201398.","journal-title":"Oncogene"},{"key":"3241_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101576","volume":"27","author":"W-M Huang","year":"2023","unstructured":"Huang W-M, Li Z-X, Wu Y-H, Shi Z-L, Mi J-L, Hu K, et al. m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis. Transl Oncol. 2023;27:101576.","journal-title":"Transl Oncol"},{"key":"3241_CR20","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/cbin.12211","volume":"48","author":"Y Liu","year":"2024","unstructured":"Liu Y, Bai Q, Pang N, Xue J. TCF12 induces ferroptosis by suppressing OTUB1-mediated SLC7A11 deubiquitination to promote cisplatin sensitivity in oral squamous cell carcinoma. Cell Biol Int. 2024;48:1649\u201363.","journal-title":"Cell Biol Int"},{"key":"3241_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-66868-3","volume":"14","author":"L Wei","year":"2024","unstructured":"Wei L, Li Y, Tan H, Peng Y, Liu Q, Zheng T, et al. OTUB1 regulates ferroptosis to inhibit myoblast differentiation into myotubes by deubiquitinating P62. Sci Rep. 2024;14:15696.","journal-title":"Sci Rep"},{"key":"3241_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/ars.2022.0202","volume":"39","author":"F Chen","year":"2023","unstructured":"Chen F, Cai X, Kang R, Liu J, Tang D. Autophagy-dependent ferroptosis in cancer. Antioxid Redox Signal. 2023;39:79\u2013101.","journal-title":"Antioxid Redox Signal"},{"key":"3241_CR23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3241_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05008-z","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Deng H, Tang J, Wang Z, Zhu C, Cai X, et al. OTUB1 augments hypoxia signaling via its non-canonical ubiquitination inhibition of HIF-1\u03b1 during hypoxia adaptation. Cell Death Dis. 2022;13:560.","journal-title":"Cell Death Dis"},{"key":"3241_CR25","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","volume":"79","author":"T Liu","year":"2019","unstructured":"Liu T, Jiang L, Tavana O, Gu W. The Deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11. Cancer Res. 2019;79:1913\u201324.","journal-title":"Cancer Res"},{"key":"3241_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156824","volume":"143","author":"L Zhang","year":"2025","unstructured":"Zhang L, Wang H, Liang B, Qin L, Zhang M, Lv X, et al. Ponicidin promotes ferroptosis to enhance treatment sensitivity in Lenvatinib-resistant hepatocellular carcinoma cells through regulation of KEAP1\/NRF2. Phytomedicine. 2025;143:156824.","journal-title":"Phytomedicine"},{"key":"3241_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","volume":"29","author":"J Chen","year":"2022","unstructured":"Chen J, Li X, Ge C, Min J, Wang F. The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 2022;29:467\u201380.","journal-title":"Cell Death Differ"},{"key":"3241_CR28","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35:830\u201349.","journal-title":"Cancer Cell"},{"key":"3241_CR29","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.7150\/ijbs.73790","volume":"18","author":"Y Meng","year":"2022","unstructured":"Meng Y, Sun H, Li Y, Zhao S, Su J, Zeng F, et al. Targeting ferroptosis by ubiquitin system enzymes: a potential therapeutic strategy in cancer. Int J Biol Sci. 2022;18:5475\u201388.","journal-title":"Int J Biol Sci"},{"key":"3241_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04708-w","volume":"13","author":"F Lin","year":"2022","unstructured":"Lin F, Chen W, Zhou J, Zhu J, Yao Q, Feng B, et al. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death Dis. 2022;13:271.","journal-title":"Cell Death Dis"},{"key":"3241_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.canlet.2021.12.002","volume":"526","author":"Y Liao","year":"2022","unstructured":"Liao Y, Yang M, Wang K, Wang Y, Zhong B, Jiang N. Deubiquitinating enzyme OTUB1 in immunity and cancer: good player or bad actor? Cancer Lett. 2022;526:248\u201358.","journal-title":"Cancer Lett"},{"key":"3241_CR32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","volume":"27","author":"J Liu","year":"2020","unstructured":"Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, Tang D. Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem Biol. 2020;27:420\u201335.","journal-title":"Cell Chem Biol"},{"key":"3241_CR33","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/15548627.2024.2319901","volume":"20","author":"X Chen","year":"2024","unstructured":"Chen X, Tsvetkov AS, Shen H-M, Isidoro C, Ktistakis NT, Linkermann A, et al. International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy. 2024;20:1213\u201346.","journal-title":"Autophagy"},{"key":"3241_CR34","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021110031","volume":"41","author":"RC Russell","year":"2022","unstructured":"Russell RC, Guan K-L. The multifaceted role of autophagy in cancer. EMBO J. 2022;41:e110031.","journal-title":"EMBO J"},{"key":"3241_CR35","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41418-023-01164-7","volume":"30","author":"X Liang","year":"2023","unstructured":"Liang X, Yao J, Cui D, Zheng W, Liu Y, Lou G, et al. The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway. Cell Death Differ. 2023;30:1550\u201362.","journal-title":"Cell Death Differ"},{"key":"3241_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110427","volume":"27","author":"C Tang","year":"2024","unstructured":"Tang C, Lai Y, Li L, Situ M-Y, Li S, Cheng B, et al. SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancer. iScience. 2024;27:110427.","journal-title":"iScience"},{"key":"3241_CR37","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41418-020-00700-z","volume":"28","author":"D Zhu","year":"2021","unstructured":"Zhu D, Xu R, Huang X, Tang Z, Tian Y, Zhang J, et al. Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1. Cell Death Differ. 2021;28:1773\u201389.","journal-title":"Cell Death Differ"},{"key":"3241_CR38","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","volume":"595","author":"H Jin","year":"2021","unstructured":"Jin H, Shi Y, Lv Y, Yuan S, Ramirez CFA, Lieftink C, et al. EGFR activation limits the response of liver cancer to lenvatinib. Nature. 2021;595:730\u20134.","journal-title":"Nature"},{"key":"3241_CR39","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/cas.15378","volume":"113","author":"N Iseda","year":"2022","unstructured":"Iseda N, Itoh S, Toshida K, Tomiyama T, Morinaga A, Shimokawa M, et al. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma. Cancer Sci. 2022;113:2272\u201387.","journal-title":"Cancer Sci"},{"key":"3241_CR40","doi-asserted-by":"crossref","unstructured":"Zhou J, Gao M, Zhang S, Guo W-W, He W, Zhang M, et al. PP1A modulates the efficacy of lenvatinib plus ICIs therapy by inhibiting ferroptosis in hepatocellular carcinoma. Adv Sci. 2025;12:e2501730.","DOI":"10.1002\/advs.202501730"},{"key":"3241_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103270","volume":"75","author":"K Zeng","year":"2024","unstructured":"Zeng K, Huang N, Liu N, Deng X, Mu Y, Zhang X, et al. LACTB suppresses liver cancer progression through regulation of ferroptosis. Redox Biol. 2024;75:103270.","journal-title":"Redox Biol"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03241-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03241-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03241-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:03:03Z","timestamp":1790154183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03241-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3241"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03241-5","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This research is reviewed by the Hepatobiliary Pancreas and Spleen Surgery, General Surgery Center, the First Hospital of Jilin University (the First Bethune Hospital of Jilin University).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"382"}}